Intellipharmaceutics International Inc. filed its Annual on Feb 28, 2022 for the period ending Nov 30, 2021. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | -.--% |
|
-11.11% | +6.67% |
1st Jan change | Capi. | |
---|---|---|
+6.67% | 1.93M | |
+52.31% | 797B | |
+40.81% | 628B | |
-6.82% | 351B | |
+17.63% | 323B | |
+11.07% | 300B | |
+17.15% | 244B | |
+0.98% | 223B | |
+5.66% | 163B | |
-5.38% | 153B |
- Stock Market
- Equities
- IPCI.H Stock
- News Intellipharmaceutics International Inc.
- Intellipharmaceutics International Inc. Auditor Raises 'Going Concern' Doubt